|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Novak Rodger
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-06-10 Sale |
2019-06-12 4:16 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
50,000 | $45 | $2,250,000 | 898,007 (Direct) |
View |
| 2019-03-01 Sale |
2019-03-05 5:59 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
85,220 | $40.4 | $3,443,037 | 1,024,534 (Direct) |
View |
| 2019-02-25 Sale |
2019-02-27 4:10 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
14,780 | $40 | $591,233 | 1,033,227 (Direct) |
View |
| 2019-01-08 Sale |
2019-01-10 4:09 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
100,000 | $35.02 | $3,502,385 | 1,130,697 (Direct) |
View |
| 2018-05-17 Sale |
2018-05-21 4:54 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
75,000 | $60 | $4,500,000 | 1,223,007 (Direct) |
View |
| 2017-08-31 Sale |
2017-09-05 6:33 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
18,470 | $20.76 | $383,393 | 1,151,860 (Direct) |
View |
| 2017-08-28 Sale |
2017-08-30 6:36 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
75,795 | $20.25 | $1,534,869 | 1,232,697 (Direct) |
View |
| 2017-06-22 Sale |
2017-06-23 4:20 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
10,825 | $15.37 | $166,388 | 1,225,830 (Direct) |
View |
| 2017-06-19 Sale |
2017-06-21 5:42 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
30,222 | $15.01 | $453,511 | 1,266,583 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2018-05-17 Exercise |
2018-05-21 4:54 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
35,240 | $1.81 | 1,223,007 (Direct) |
View |
| 2018-05-17 Exercise |
2018-05-21 4:54 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
39,760 | $14 | 1,223,007 (Direct) |
View |
| 2018-05-17 Exercise |
2018-05-21 4:54 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
35,240 | $1.81 | 1,223,007 (Direct) |
View |
| 2018-05-17 Exercise |
2018-05-21 4:54 pm |
N/A 2016-10-18 |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
39,760 | $14 | 1,223,007 (Direct) |
View |
| 2017-08-31 Exercise |
2017-09-05 6:33 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
3,853 | $1.81 | 1,151,860 (Direct) |
View |
| 2017-08-31 Exercise |
2017-09-05 6:33 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
3,853 | $1.81 | 1,151,860 (Direct) |
View |
| 2017-08-28 Exercise |
2017-08-30 6:36 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
17,692 | $1.81 | 1,232,697 (Direct) |
View |
| 2017-08-28 Exercise |
2017-08-30 6:36 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
5,722 | $1.81 | 1,232,697 (Direct) |
View |
| 2017-08-28 Exercise |
2017-08-30 6:36 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
17,692 | $1.81 | 1,232,697 (Direct) |
View |
| 2017-08-28 Exercise |
2017-08-30 6:36 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
5,722 | $1.81 | 1,232,697 (Direct) |
View |
| 2017-06-22 Exercise |
2017-06-23 4:20 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
10,825 | $1.81 | 1,225,830 (Direct) |
View |
| 2017-06-22 Exercise |
2017-06-23 4:20 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
10,825 | $1.81 | 1,225,830 (Direct) |
View |
| 2017-06-19 Exercise |
2017-06-21 5:42 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
15,392 | $1.81 | 1,266,583 (Direct) |
View |
| 2017-06-19 Exercise |
2017-06-21 5:42 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
3,252 | $1.81 | 1,266,583 (Direct) |
View |
| 2017-06-19 Exercise |
2017-06-21 5:42 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
11,578 | $1.81 | 1,266,583 (Direct) |
View |
| 2017-06-19 Exercise |
2017-06-21 5:42 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
15,392 | $1.81 | 1,266,583 (Direct) |
View |
| 2017-06-19 Exercise |
2017-06-21 5:42 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
3,252 | $1.81 | 1,266,583 (Direct) |
View |
| 2017-06-19 Exercise |
2017-06-21 5:42 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Novak Rodger CEO |
11,578 | $1.81 | 1,266,583 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Thu, 20 Jun 2019 00:13:54 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |